Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies.
Fox ML, García-Cadenas I, Navarro V, Martínez AP, Kara M, Bazán IS, Ferra Coll C, Bailén R, Bento L, Parody R, Esquirol A, Ortí G, Mussetti A, Salamero O, Martino R, González AP, Barba P, Kwon M, Solano C, Bosch F, Valcárcel D; Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC).
Fox ML, et al. Among authors: gonzalez ap.
Bone Marrow Transplant. 2024 Jun 24. doi: 10.1038/s41409-024-02322-2. Online ahead of print.
Bone Marrow Transplant. 2024.
PMID: 38914883